Clinicopathological analysis of malignant lymphoma in Taiwan, defined according to the World Health Organization classification

Haematologica

Volumn 90, Issue 12, 2005, Pages 1703-1705

  Lee, Ming Yuan ^a,b   Tan, Tran Der ^a   Feng, An Chen ^a   Liu, Mei Ching ^a  

^a KOO FOUNDATION SUN YAT SEN CANCER CENTER   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Malignant lymphoma; Taiwan; WHO classification

Indexed keywords

ARTICLE; ASIAN; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; GEOGRAPHIC DISTRIBUTION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; NATURAL KILLER T CELL; PATHOLOGY; T CELL LYMPHOMA; TAIWAN; WORLD HEALTH ORGANIZATION;

FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; JAPAN; KOREA; LYMPHOMA; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MALE; SURVIVAL RATE; TAIWAN; THAILAND; WORLD HEALTH ORGANIZATION;

EID: 29144439757     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. Tumours of Hematopoietic and Lymphoid Tissues. LARC press, Lyon: 2001.
2. Ko YH, Kim CW, Park CS, Jang HK, Lee SS, Kim SH, et al. REAL Classification of malignant lymphomas in Republic of Korea. Cancer 1998;83:806-12.
3. Lee SS, Cho KJ, Kim CW, Kang YK. Clinicopathological analysis of 501 non-Hodgkin's lymphomas in Korea according to the revised European-American classification of lymphoid neoplasms. Histopathology 1999;35:345-54.
4. Lymphoma study group of Japanese pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int 2000;50:696-702.
5. Isobe K, Tamaru J, Harigaya K, Mikata A, Ito H. Clinico-pathological evaluation of the revised European-American classification of lymphoid neoplasms in Japan. Leuk Lymphoma 1999;34:143-9.
6. Sukpanichnant S, Sonakul D, Piankijagum A, Wanachiwanawin W, Veerakul G, Mahasandana C, et aL Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj hospital. Cancer 1998;83:1197-204.
7. Melnyk A, Ridriguez A, Pugh WC, Cabanillas F. Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997;98:4514-20.
8. The non-Hodgkin's lymphoma classification project: a clinical evaluation of the international lymphoma study groups classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
9. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J, Haioun C, et al. Prognostic significance of T cell phenotype in aggressive non-Hodgkin's lymphoma. Blood 1998;2:76-82.
10. Glaser SL, Hsu JL. Hodgkin's disease in Asians: incidence paterns and risk factors in population-based data. Leuk Res 2002;26:261-9.